About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in New York | 32 Studies

Clinical Trials MigraineNew York

Migraine Clinical Trials in New York

Find 32 clinical trials for migraine near New York, New York. Connect with research centers in your area.

All Migraine trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 32 trials

RecruitingLong-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineThe purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).NCT04743141·Scottsdale, Arizona and 123 others

Migraine Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineIn this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck.NCT07018700·Chandler, Arizona and 109 others

CompletedDose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of MigraineThe primary purpose of this study is to evaluate the efficacy of rimegepant (BMS-927711) compared with placebo in the acute treatment of migraine as measured by Pain Freedom…NCT01430442·Scottsdale, Arizona and 40 others

RecruitingA Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.NCT07674654·Birmingham, Alabama and 112 others

CompletedNon-Invasive Neurostimulation For the Relief of Symptoms Associated With MigraineThe purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment…NCT01532830·San Francisco, California and 2 others

CompletedStudy to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound.NCT05264129·Birmingham, Alabama and 36 others

CompletedStudy to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult ParticipantsStudy to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine When Administered During the ProdromeNCT04492020·Birmingham, Alabama and 72 others

RecruitingA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineIn this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck.NCT07018713·Chandler, Arizona and 110 others

TerminatedA Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionThe purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT04804033·Phoenix, Arizona and 115 others

CompletedEfficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsThe purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT03732638·Chandler, Arizona and 92 others

CompletedTopical Intra-Oral Ketoprofen for Migraine PreventionIntra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been shown to prevent migraines when used once daily for 3 months in open label studies.NCT01211795·Valhalla, New York

CompletedInvestigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsThis Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per month.NCT04845178·Chandler, Arizona and 61 others

TerminatedStudy to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in AdolescentsThis study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent…NCT03338920·Phoenix, Arizona and 39 others

CompletedSafety and Efficacy Study in Adult Subjects With Acute MigrainesThe purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute MigrainesNCT03235479·Birmingham, Alabama and 49 others

CompletedOpen Label Safety Study in Acute Treatment of MigraineThe purpose of this study is to evaluate safety and tolerability of BHV-3000 (rimegepant).NCT03266588·Birmingham, Alabama and 97 others

WithdrawnProtective HA FactorsThis is a naturalistic study of 100 migraineurs and 75 post concussive headache patients who will be asked to record their headaches, medications, sleep and other behaviors in a…NCT02748174·New York, New York

RecruitingA Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of…NCT07645924·Birmingham, Alabama and 112 others

WithdrawnImproving Health Outcomes of Migraine Patients Who Present to the Emergency DepartmentCollectively, evidence shows that a combination of medication and behavioral therapy is most effective for migraine care.NCT02945839·New York, New York

CompletedA Study of Home-Delivered Neurostimulation for MigraineThere is a need for better preventive and abortive therapies for migraine.NCT03874351·New York, New York and 1 other

CompletedStaccato Prochlorperazine in Migraine (Out Patient)Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches.NCT00422812·Scottsdale, Arizona and 24 others

Page 1 of 2Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia